Association between Obesity and COVID-19 Outcomes in the Intensive Care Unit of RSUP Dr. M. Djamil Padang
DOI:
https://doi.org/10.36497/jri.v42i4.342Keywords:
COVID-19, obesity, length of stay, length of conversion, mortalityAbstract
Background: Obesity is one of the risk factors for severe clinical COVID-19. This is because these patients tend to have comorbidities such as metabolic disease and cardiovascular disease. Obesity may result in poor outcomes, such as prolonged hospital stays, higher incidence of ARDS and mortality. The purpose of this study was to determine the correlation between obesity and the outcome of confirmed COVID-19 patients.
Methods: This was an analytical study with retrospective cohort design on COVID-19 patients treated in the intensive care unit (ICU)of RSUP Dr. M. Djamil Padang. Data were taken from patients’ medical records between November 2021 and February 2022. The correlation between obesity with length of stay and patient mortality was analyzed using Chi-square test. Odds ratio was also assessed.
Results: This study obtained that the characteristics of obese COVID-19 patients were mainly women (54.20%). The most dominant age group was 60-69 years (31.3%). About83.3% of obese patients were found to be clinically critical. Inflammatory markers such as procalcitonin, ferritin, IL-6 and d-dimer were not significantly associated with obesity. Diabetes mellitus was significantly related to the outcome of COVID-19 patients with obesity and without obesity (0.009%). Obesity was not correlated with hospital length of stay of COVID-19 patients, but was significantly associated with length of stay in the ICU [OR 3.67 (95% CI, 1.09-12.35)]. Obesity was significantly associated with mortality [OR 2.84 (95% CI, 1.12-7.18)] and length of conversion for COVID-19 patients in the ICU [OR 30.00 (95% CI, 2.85-31, 61)]. The expansion of adipose tissue both subcutaneously and viscerally which could be observed in obese patients can increase the proinflammatory, prothrombotic, and vasoconstrictive state that might affect the clinical deterioration of COVID-19 patients. This condition also manifests as insulin resistance, hypertension, atherosclerosis, cardiovascular disease and immunocompromised conditions which can generate high mortality rate.
Conclusion: Obesity was found to be significantly associated with mortality, conversion time and length of stay for COVID-19 patients in the ICU.
Downloads
References
World Health Organization. Clinical management of COVID-19: Living guideline, 23 June 2022. 4th ed. Geneva: World Health Organization; 2022. 11–12 p.
Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–6.
Albashir AAD. The potential impacts of obesity on COVID-19. Clin Med. 2020;20(4):e109–13.
Rao X, Wu C, Wang S, Tong S, Wang G, Wu G, et al. The importance of overweight in COVID-19: A retrospective analysis in a single center of Wuhan, China. Medicine (Baltimore). 2020;99(43):e22766.
Bello-Chavolla OY, Bahena-López JP, Antonio-Villa NE, Vargas-Vázquez A, González-Díaz A, Márquez-Salinas A, et al. Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in mexico. J Clin Endocrinol Metab. 2020;105(8):dgaa346.
Yu W, Rohli KE, Yang S, Jia P. Impact of obesity on COVID-19 patients. J Diabetes Complications. 2021;35(3):107817.
Moriconi D, Masi S, Rebelos E, Virdis A, Manca ML, De Marco S, et al. Obesity prolongs the hospital stay in patients affected by COVID-19, and may impact on SARS-COV-2 shedding. Obes Res Clin Pract. 2020;14(3):205–9.
Dreher M, Kersten A, Bickenbach J, Balfanz P, Hartmann B, Cornelissen C, et al. The characteristics of 50 hospitalized COVID-19 patients with and without ARDS. Dtsch Arztebl Int. 2020;117(16):271–8.
Gupta S, Hayek SS, Wang W, Chan L, Mathews KS, Melamed ML, et al. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Intern Med. 2020;180(11):1436–47.
Dana R, Bannay A, Bourst P, Ziegler C, Losser M-R, Gibot S, et al. Obesity and mortality in critically ill COVID-19 patients with respiratory failure. Int J Obes (Lond). 2021;45(9):2028–37.
Pettit NN, MacKenzie EL, Ridgway JP, Pursell K, Ash D, Patel B, et al. Obesity is associated with increased risk for mortality among hospitalized patients with COVID-19. Obesity (Silver Spring). 2020;28(10):1806–10.
Surendra H, Elyazar IR, Djaafara BA, Ekawati LL, Saraswati K, Adrian V, et al. Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: A hospital-based retrospective cohort study. Lancet Reg Heal - West Pacific. 2021;9:100108.
Huang Y, Lu Y, Huang Y-M, Wang M, Ling W, Sui Y, et al. Obesity in patients with COVID-19: a systematic review and meta-analysis. Metabolism. 2020;113:154378.
Shahid Z, Kalayanamitra R, McClafferty B, Kepko D, Ramgobin D, Patel R, et al. COVID-19 and older adults: What we know. J Am Geriatr Soc. 2020;68(5):926–9.
Aslan G, Arli SK, Bakan AB. Obesity and risk factors in women aged between 18 and 64. Int J Caring Sci. 2019;12(1):218–23.
Bwire GM. Coronavirus: Why men are more vulnerable to COVID-19 than women? SN Compr Clin Med. 2020;2(7):874–6.
Zhang H, Han H, He T, Labbe KE, Hernandez A V, Chen H, et al. Clinical characteristics and outcomes of COVID-19-infected cancer patients: A systematic review and meta-analysis. J Natl Cancer Inst. 2021;113(4):371–80.
Cai Z, Yang Y, Zhang J. Obesity is associated with severe disease and mortality in patients with coronavirus disease 2019 (COVID-19): a meta-analysis. BMC Public Health. 2021;21(1):1505.
Ellulu MS, Patimah I, Khaza’ai H, Rahmat A, Abed Y. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. 2017;13(4):851–63.
Rosário Ferreira ME, Santos de Andrade AV, Ferreira Queiroz AA, Martins-Filho PR, de Aquino Neves EL, Oliveira de Carvalho F, et al. COVID-19 and obesity: a systematic review and meta-analysis on the pre-existing clinical conditions, COVID-19 symptoms, laboratory findings and clinical outcomes. EXCLI J. 2021;20:1610–4.
Parmar M. Obesity and Type 2 diabetes mellitus. Integr Obes Diabetes. 2018;4.
Al Heialy S, Hachim MY, Hachim IY, Bin Naeem K, Hannawi H, Lakshmanan J, et al. Combination of obesity and co-morbidities leads to unfavorable outcomes in COVID-19 patients. Saudi J Biol Sci. 2021;28(2):1445–50.
Pouwels S, Ramnarain D, Aupers E, Rutjes-Weurding L, van Oers J. Obesity May Not Be Associated with 28-Day Mortality, Duration of Invasive Mechanical Ventilation and Length of Intensive Care Unit and Hospital Stay in Critically Ill Patients with Severe Acute Respiratory Syndrome Coronavirus-2: A Retrospective Cohort St. Med. 2021;57(7):674.
Poly TN, Islam MM, Yang HC, Lin MC, Jian W-S, Hsu M-H, et al. Obesity and mortality among patients diagnosed with COVID-19: A systematic review and meta-analysis. Front Med. 2021;8:620044.
Osibogun A, Balogun M, Abayomi A, Idris J, Kuyinu Y, Odukoya O, et al. Outcomes of COVID-19 patients with comorbidities in southwest Nigeria. PLoS One. 2021;16(3):e0248281.
Tartof SY, Qian L, Hong V, Wei R, Nadjafi RF, Fischer H, et al. Obesity and mortality among patients diagnosed with COVID-19: Results from an integrated health care organization. Ann Intern Med. 2020;173(10):773–81.
Shariq OA, McKenzie TJ. Obesity-related hypertension: a review of pathophysiology, management, and the role of metabolic surgery. Gland Surg. 2020;9(1):80–93.
Pugliese G, Liccardi A, Graziadio C, Barrea L, Muscogiuri G, Colao A. Obesity and infectious diseases: pathophysiology and epidemiology of a double pandemic condition. Int J Obes (Lond). 2022;46(3):449–65.
Ni Y-N, Yu H, Xu H, Li W-J, Liang B-M, Yang L, et al. High visceral adipose tissue to subcutaneous adipose tissue ratio as a predictor of mortality in acute respiratory distress syndrome. Am J Med Sci. 2019;357(3):213–22.
Bennasrallah C, Zemni I, Dhouib W, Sriha H, Mezhoud N, Bouslama S, et al. Factors associated with a prolonged negative conversion of viral RNA in patients with COVID-19. Int J Infect Dis. 2021;105:463–9.
Mo P, Deng L, Liu X, Gao S, Liang K, Luo M, et al. Risk factors for delayed negative conversion of SARS-CoV-2 in patients with COVID-19 pneumonia: a retrospective cohort study. Epidemiol Infect. 2020;148:e293.
Zhang X, Lin B, Yang G, Liu L, Lu J, Lu Z, et al. Delayed SARS-CoV-2 clearance in patients with obesity. Infect Drug Resist. 2021;14:2823–7.
Demeulemeester F, de Punder K, van Heijningen M, van Doesburg F. Obesity as a Risk Factor for Severe COVID-19 and Complications: A Review. Cells. 2021;10(4):933.
Angelidi AM, Belanger MJ, Mantzoros CS. Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next. Metabolism. 2020;107:154245.
Sjögren L, Stenberg E, Thuccani M, Martikainen J, Rylander C, Wallenius V, et al. Impact of obesity on intensive care outcomes in patients with COVID-19 in Sweden-A cohort study. PLoS One. 2021;16(10):e0257891.
Suresh S, Siddiqui M, Abu Ghanimeh M, Jou J, Simmer S, Mendiratta V, et al. Association of obesity with illness severity in hospitalized patients with COVID-19: A retrospective cohort study. Obes Res Clin Pract. 2021;15(2):172–6.
Plataki M, Pan D, Goyal P, Hoffman K, Choi JMK, Huang H, et al. Association of body mass index with morbidity in patients hospitalised with COVID-19. BMJ open Respir Res. 2021;8(1).
Downloads
Additional Files
Published
Issue
Section
License
- The authors own the copyright of published articles. Nevertheless, Jurnal Respirologi Indonesia has the first-to-publish license for the publication material.
- Jurnal Respirologi Indonesia has the right to archive, change the format and republish published articles by presenting the authors’ names.
- Articles are published electronically for open access and online for educational, research, and archiving purposes. Jurnal Respirologi Indonesia is not responsible for any copyright issues that might emerge from using any article except for the previous three purposes.
